Jeff M.P. Holly

10.5k total citations
202 papers, 7.3k citations indexed

About

Jeff M.P. Holly is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Oncology. According to data from OpenAlex, Jeff M.P. Holly has authored 202 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 131 papers in Endocrinology, Diabetes and Metabolism, 91 papers in Molecular Biology and 47 papers in Oncology. Recurrent topics in Jeff M.P. Holly's work include Growth Hormone and Insulin-like Growth Factors (126 papers), Metabolism, Diabetes, and Cancer (54 papers) and Cancer, Hypoxia, and Metabolism (34 papers). Jeff M.P. Holly is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (126 papers), Metabolism, Diabetes, and Cancer (54 papers) and Cancer, Hypoxia, and Metabolism (34 papers). Jeff M.P. Holly collaborates with scholars based in United Kingdom, Norway and United States. Jeff M.P. Holly's co-authors include Claire M. Perks, David Gunnell, Claire E. Stewart, George Davey Smith, Richard M. Martin, David B. Dunger, Paul V. Newcomb, Catherine McCaig, Susan E. Hankinson and Michaël Pollak and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Jeff M.P. Holly

202 papers receiving 7.1k citations

Peers

Countries citing papers authored by Jeff M.P. Holly

Since Specialization

Citations

This map shows the geographic impact of Jeff M.P. Holly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeff M.P. Holly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeff M.P. Holly more than expected).

Fields of papers citing papers by Jeff M.P. Holly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeff M.P. Holly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeff M.P. Holly. The network helps show where Jeff M.P. Holly may publish in the future.

Co-authorship network of co-authors of Jeff M.P. Holly

This figure shows the co-authorship network connecting the top 25 collaborators of Jeff M.P. Holly. A scholar is included among the top collaborators of Jeff M.P. Holly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeff M.P. Holly. Jeff M.P. Holly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Role of Insulin-like Growth Factor Binding Protein (IGFBP)-2 in DNA Repair and Chemoresistance in Breast Cancer Cells 2024 ·Cancers ·(unknown), Kalina Biernacka, Rachel Barker, Jeff M.P. Holly, Claire M. Perks	2
2	A Single-arm Phase II Trial of Neoadjuvant Cabazitaxel and Cisplatin Chemotherapy for Muscle-Invasive Transitional Cell Carcinoma of the Urinary Bladder 2021 ·Clinical Genitourinary Cancer ·Amarnath Challapalli, (unknown), Paul White, (unknown), S.K. Pearson, Edward Rowe, Anthony Koupparis, Jon Oxley, (unknown), (unknown), Alicia Bravo, Emily Foulstone, Claire M. Perks, Jeff M.P. Holly, Raj Persad, Amit Bahl	4
3	IGFBP-1 expression is reduced in human type 2 diabetic glomeruli and modulates β1-integrin/FAK signalling in human podocytes 2021 ·Diabetologia ·Abigail C. Lay, Lorna J. Hale, (unknown), Robert J. P. Pope, Viji Nair, Wenjun Ju, Eva Márquez, Ruth Rollason, Jenny Hurcombe, (unknown), Timothy K. Roberts, (unknown), (unknown), Robert G. Nelson, Matthias Kretzler, Jeff M.P. Holly, Claire M. Perks, Craig A. McArdle, Gavin I. Welsh, Richard J. Coward	25
4	Alteration of Metabolic Conditions Impacts the Regulation of IGF-II/H19 Imprinting Status in Prostate Cancer 2021 ·Cancers ·(unknown), Kalina Biernacka, (unknown), (unknown), Rachel Barker, Hanna Zielińska, Amanda Gilkes, Kathryn McCarthy, Richard M. Martin, J. Athene Lane, (unknown), Anthony Koupparis, Edward Rowe, Jon Oxley, Jeff M.P. Holly, Claire M. Perks	6
5	A Role for ER-Beta in the Effects of Low-Density Lipoprotein Cholesterol and 27-Hydroxycholesterol on Breast Cancer Progression: Involvement of the IGF Signalling Pathway? 2021 ·Cells ·(unknown), Hanna Zielińska, Jeff M.P. Holly, Claire M. Perks	9
6	Interaction between GRP78 and IGFBP-3 Affects Tumourigenesis and Prognosis in Breast Cancer Patients 2020 ·Cancers ·Hanna Zielińska, (unknown), Ahmad Al-Ghamdi, Amit Bahl, (unknown), Paul White, (unknown), Jeff M.P. Holly, Claire M. Perks	18
7	Phase II randomised control feasibility trial of a nutrition and physical activity intervention after radical prostatectomy for prostate cancer 2019 ·BMJ Open ·(unknown), Chris Penfold, (unknown), (unknown), Claire M. Perks, Jeff M.P. Holly, Edward Rowe, Anthony Koupparis, Amit Bahl, Raj Persad, Constance Shiridzinomwa, Lyndsey Johnson, Kalina Biernacka, (unknown), Jayne V. Woodside, Sarah Gilchrist, Jon Oxley, Paul Abrams, J. Athene Lane, Richard M. Martin	10
8	ProDiet: A Phase II Randomized Placebo-controlled Trial of Green Tea Catechins and Lycopene in Men at Increased Risk of Prostate Cancer 2018 ·Cancer Prevention Research ·J. Athene Lane, Vanessa Er, Kerry Avery, Jeremy Horwood, Marie M. Cantwell, (unknown), Alan Crozier, George Davey Smith, Jenny Donovan, Liz Down, Freddie C. Hamdy, David Gillatt, Jeff M.P. Holly, Rhiannon Macefield, (unknown), David E. Neal, Eleanor Walsh, Richard M. Martin, Chris Metcalfe	33
9	Reassessing the Association between Circulating Vitamin D and IGFBP-3: Observational and Mendelian Randomization Estimates from Independent Sources 2018 ·Cancer Epidemiology Biomarkers & Prevention ·Vanessa Y. Tan, Kalina Biernacka, Tom Dudding, Carolina Bonilla, Rebecca Gilbert, Robert C. Kaplan, Qibin Qi, Alexander Teumer, Richard M. Martin, Claire M. Perks, Nicholas J. Timpson, Jeff M.P. Holly	6
10	Caffeine and Caffeic Acid Inhibit Growth and Modify Estrogen Receptor and Insulin-like Growth Factor I Receptor Levels in Human Breast Cancer 2015 ·Clinical Cancer Research ·Ann H. Rosendahl, Claire M. Perks, Li Zeng, Andrea Markkula, Maria Simonsson, Carsten Rose, Christian Ingvar, Jeff M.P. Holly, Helena Jernström	129
11	Epigenetic regulation of insulin-like growth factor binding protein-3 (IGFBP-3) in cancer 2015 ·Journal of Cell Communication and Signaling ·Claire M. Perks, Jeff M.P. Holly	19
12	Circulating Insulin-Like Growth Factors and IGF-Binding Proteins in PSA-Detected Prostate Cancer: The Large Case–Control Study ProtecT 2011 ·Cancer Research ·Mari‐Anne Rowlands, Jeff M.P. Holly, David Gunnell, Jenny Donovan, J. Athene Lane, Freddie C. Hamdy, David E. Neal, Steven Oliver, George Davey Smith, Richard M. Martin	42
13	Premenopausal Mammographic Density in Relation to Cyclic Variations in Endogenous Sex Hormone Levels, Prolactin, and Insulin-like Growth Factors 2009 ·Cancer Research ·Kate Walker, Olivia Fletcher, Nichola Johnson, Ben Coupland, Valerie McCormack, Elizabeth Folkerd, Lorna J. Gibson, Stephen G. Hillier, Jeff M.P. Holly, Sue Moss, Mitch Dowsett, Julian Peto, Isabel dos‐Santos‐Silva	54
14	IGF-axis and screen-detected prostate cancer: A cross-sectional study 2003 ·The Journal of Urology ·Steven Oliver, Kieran Jefferson, David Gunnell, Raj Persad, J L Donovan, T. J. Peters, David Gillatt, Alison Pearce, Freddie C. Hamdy, David E. Neal, Jeff M.P. Holly	1
15	Are diet–prostate cancer associations mediated by the IGF axis? A cross-sectional analysis of diet, IGF-1 and IGFBP-3 in healthy middle-aged men 2003 ·British Journal of Cancer ·David Gunnell, Steven Oliver, T. J. Peters, Jenny Donovan, Raj Persad, Maria Maynard, David Gillatt, (unknown), Freddie C. Hamdy, David E. Neal, Jeff M.P. Holly	102
16	What is the role of the insulin‐like growth factor system in the pathophysiology of cancer cachexia, and how is it regulated? 2002 ·Clinical Endocrinology ·(unknown), (unknown), Stafford L. Lightman, Stephen Falk, Vidya Mohamed‐Ali, L Armstrong, Ann Millar, Jeff M.P. Holly	47
17	The Role of Cell Surface Attachment and Proteolysis in the Insulin-Like Growth Factor (IGF)-Independent Effects of IGF-Binding Protein-3 on Apoptosis in Breast Epithelial Cells 1999 ·Endocrinology ·Laura A. Maile, (unknown), Claire M. Perks, Jeff M.P. Holly	28
18	Active and Inhibitory Components of the Insulin-Like Growth Factor Binding Protein-3 Protease System in Adult Serum, Interstitial, and Synovial Fluid 1998 ·Endocrinology ·Laura A. Maile, Su Xu, S C Cwyfan-Hughes, Janet K. Fernihough, Jennifer M. Pell, Jeff M.P. Holly	18
19	Influence of treatment with tamoxifen and change in tumor burden on the IGF‐system in breast cancer patients 1996 ·International Journal of Cancer ·Svein Inge Helle, Jeff M.P. Holly, Michael Tally, Kerstin Hall, (unknown), Per Eystein Lønning	1
20	Insulin like growth factor-I, insulin like growth factor binding protein-1, and insulin in childhood Crohn's disease. 1993 ·Gut ·Adrian G. Thomas, Jeff M.P. Holly, F. Taylor, Vivien Miller	80

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact